241 related articles for article (PubMed ID: 16081512)
21. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
22. XPC gene mutations in families with xeroderma pigmentosum from Pakistan; prevalent founder effect.
Ijaz A; Basit S; Gul A; Batool L; Hussain A; Afzal S; Ramzan K; Ahmad J; Wali A
Congenit Anom (Kyoto); 2019 Jan; 59(1):18-21. PubMed ID: 29569758
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.
Nasrallah A; Fayyad N; Kobaisi F; Badran B; Fayyad-Kazan H; Fayyad-Kazan M; Sève M; Rachidi W
Oxid Med Cell Longev; 2021; 2021():6689403. PubMed ID: 34630850
[TBL] [Abstract][Full Text] [Related]
24. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
Nikolaev S; Yurchenko AA; Sarasin A
Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
[TBL] [Abstract][Full Text] [Related]
27. Whole Exome Sequencing of a Patient with a Milder Phenotype of Xeroderma Pigmentosum Group C.
Seo JI; Nishigori C; Ahn JJ; Ryu JY; Lee J; Lee MH; Kim SK; Jeong KH
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109656
[TBL] [Abstract][Full Text] [Related]
28. Xeroderma pigmentosum-variant patients from America, Europe, and Asia.
Inui H; Oh KS; Nadem C; Ueda T; Khan SG; Metin A; Gozukara E; Emmert S; Slor H; Busch DB; Baker CC; DiGiovanna JJ; Tamura D; Seitz CS; Gratchev A; Wu WH; Chung KY; Chung HJ; Azizi E; Woodgate R; Schneider TD; Kraemer KH
J Invest Dermatol; 2008 Aug; 128(8):2055-68. PubMed ID: 18368133
[TBL] [Abstract][Full Text] [Related]
29. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
30. Three nonsense mutations responsible for group A xeroderma pigmentosum.
Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
[TBL] [Abstract][Full Text] [Related]
31. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
32. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
33. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
34. Founder mutations in xeroderma pigmentosum.
Tamura D; DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2010 Jun; 130(6):1491-3. PubMed ID: 20463673
[TBL] [Abstract][Full Text] [Related]
35. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
Mimaki T; Tanaka K; Nagai A; Mino M
Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
[TBL] [Abstract][Full Text] [Related]
36. Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.
Pugh J; Khan SG; Tamura D; Goldstein AM; Landi MT; DiGiovanna JJ; Kraemer KH
JAMA Dermatol; 2019 Jan; 155(1):72-78. PubMed ID: 30516811
[TBL] [Abstract][Full Text] [Related]
37. Atypical Clinical Presentation of Xeroderma Pigmentosum in a Patient Harboring a Novel Missense Mutation in the XPC Gene: The Importance of Clinical Suspicion.
Meneses M; Chavez-Bourgeois M; Badenas C; Villablanca S; Aguilera P; Bennàssar A; Alos L; Puig S; Malvehy J; Carrera C
Dermatology; 2015; 231(3):217-21. PubMed ID: 26278556
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
39. Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC.
Bernardes de Jesus BM; Bjørås M; Coin F; Egly JM
Mol Cell Biol; 2008 Dec; 28(23):7225-35. PubMed ID: 18809580
[TBL] [Abstract][Full Text] [Related]
40. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
